By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > Drugs A-Z > Biguanide (diabetes) > Metformin

Metformin

GMJ
Last updated: 02/06/2026 14:30
By
Prof. Giorgi Pkhakadze
Share
5 Min Read
SHARE
3 min read|681 words

Metformin: A First-Line Diabetes Medication

What is Metformin?

Metformin is an oral medication belonging to the biguanide class of drugs, primarily used to treat type 2 diabetes mellitus. It is widely considered the first-line treatment for type 2 diabetes and is one of the most commonly prescribed diabetes medications worldwide. Metformin helps control blood sugar levels and improve insulin sensitivity in people with diabetes.

Uses

Metformin has several documented medical uses:

  • Type 2 diabetes management: The primary FDA-approved use, helping to control blood glucose levels as part of a comprehensive treatment plan that includes diet and exercise.
  • Prediabetes prevention: Used to delay or prevent the onset of type 2 diabetes in high-risk individuals with prediabetes.
  • Polycystic ovary syndrome (PCOS): Often prescribed off-label to help manage insulin resistance and hormonal imbalances associated with PCOS.
  • Gestational diabetes: Sometimes used during pregnancy when diet and exercise alone are insufficient to control blood sugar levels.
  • Weight management: May be prescribed off-label for weight loss in obese patients with insulin resistance, particularly when combined with lifestyle modifications.

How it works

Metformin works through multiple mechanisms to lower blood glucose levels. It primarily reduces the amount of glucose produced by the liver, decreases glucose absorption in the intestines, and improves insulin sensitivity in muscle and fat tissues. Unlike some other diabetes medications, metformin does not increase insulin production, which helps reduce the risk of dangerously low blood sugar levels.

Side effects

Common side effects include:

Submit Your Paper
GMJ_Submit_Banner
  • Nausea and vomiting
  • Diarrhea
  • Stomach upset or abdominal discomfort
  • Loss of appetite
  • Metallic taste in mouth
  • Gas and bloating
  • Heartburn
  • Headache

Serious side effects to watch for:

  • Lactic acidosis (rare but potentially life-threatening buildup of lactic acid)
  • Severe kidney problems or kidney failure
  • Liver problems
  • Vitamin B12 deficiency with long-term use
  • Severe allergic reactions

Warnings and precautions

  • Kidney function monitoring: Metformin should be used with caution or avoided in patients with kidney disease, as reduced kidney function can increase the risk of lactic acidosis.
  • Liver disease: Patients with liver impairment should use metformin cautiously, as liver dysfunction can increase the risk of lactic acidosis.
  • Pregnancy considerations: Metformin is classified as FDA pregnancy category B and may be used during pregnancy when benefits outweigh risks, particularly for gestational diabetes.
  • Surgery and imaging procedures: Metformin should be temporarily discontinued before certain medical procedures involving contrast dyes or during periods of reduced food and fluid intake.
  • Alcohol consumption: Heavy alcohol use should be avoided while taking metformin due to increased risk of lactic acidosis.

Interactions

  • Contrast dyes: Iodinated contrast agents used in imaging studies can increase the risk of kidney problems and lactic acidosis when combined with metformin.
  • Diuretics: Water pills can affect kidney function and may increase the risk of lactic acidosis when used with metformin.
  • Corticosteroids: These medications can raise blood sugar levels, potentially reducing metformin’s effectiveness.
  • Alcohol: Excessive alcohol consumption increases the risk of lactic acidosis and can affect blood sugar control.
  • Insulin and sulfonylureas: When combined with metformin, these medications may increase the risk of low blood sugar.
  • Cimetidine: This acid reducer can increase metformin levels in the blood, potentially leading to side effects.
  • Topiramate: This seizure medication may increase the risk of lactic acidosis when combined with metformin.
  • Carbonic anhydrase inhibitors: These medications may increase the risk of lactic acidosis when used with metformin.

Check interactions with the GMJ Interaction Checker

Dosage

Typical adult dosages for metformin vary based on the formulation and individual patient needs. For immediate-release tablets, the usual starting dose is 500 mg twice daily or 850 mg once daily with meals, gradually increased to a maximum of 2,550 mg per day divided into two or three doses. Extended-release formulations typically start at 500-1,000 mg once daily with the evening meal, with a maximum dose of 2,000 mg daily. Dosage adjustments are often necessary based on blood glucose response, kidney function, and tolerability. Healthcare providers should always determine the appropriate dosage based on individual patient factors and treatment goals.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

Cite this page

GMJ News Desk. "Metformin." GMJ News — Georgian Medical Journal, 2 June 2026. https://news.gmj.ge/drug/metformin/

CC BY 4.0This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).

Was this article helpful?

Related topics

Optional further reading from the GMJ knowledge base.

In the news
Orforglipron Shows Clinically Significant HbA1c Reductions in Type 2 Diabetes Plasma protein signatures reveal how individual cell types age and predict disease risk Reversing Prediabetes Cuts Cardiovascular Death Risk by 58%, Long-term Studies Show
In the news
  • Orforglipron Shows Clinically Significant HbA1c Reductions in Type 2 Diabetes · Jul 9, 2026
  • Plasma protein signatures reveal how individual cell types age and predict disease risk · Jul 9, 2026
  • Reversing Prediabetes Cuts Cardiovascular Death Risk by 58%, Long-term Studies Show · Jul 2, 2026
  • Longevity Science Attracts $5.2 Billion in Investment as Movement Shifts from Fringe to Mainstream · Jun 22, 2026
Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByProf. Giorgi Pkhakadze
Follow:
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
UK Releases Rabies Post-Exposure Risk Assessment Tool for Clinical Practice

The UK Department of Health and Social Care has published a standardised…

UK Sets Minimum Age of 11 for Puberty Blocker Clinical Trial in Gender-Questioning Children

The UK has set a minimum age of 11 years for children…

Why Women Choose Freebirth: What Research Reveals About Unattended Childbirth

A growing number of women are choosing unattended childbirth, driven by desire…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up